SEC Form 4 · accession 0001140361-15-001481
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chang Ho Ahn
Director
Period of report
Jan 8, 2015
Accepted (ET)
Jan 12, 2015 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001228627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2015 | M | 80,000 | $0.80 | A | 6,090,000 | D | |
| Common StockF2 | Jan 8, 2015 | S | 80,000 | $0.9004 | D | 6,010,000 | D | |
| Common Stock | Jan 9, 2015 | M | 186,212 | $0.80 | A | 6,196,212 | D | |
| Common StockF3 | Jan 9, 2015 | S | 186,212 | $0.9155 | D | 6,010,000 | D | |
| Common Stock | Jan 12, 2015 | M | 48,444 | $0.80 | A | 6,058,444 | D | |
| Common StockF4 | Jan 12, 2015 | S | 48,444 | $0.9137 | D | 6,010,000 | D | |
| Common StockF5 | holding | — | — | — | 500,000 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F6 | $0.80 | Jan 8, 2015 | M | 80,000 | D | — | Jan 20, 2015 | Common Stock | 80,000 | 783,807 | D |
| Stock Option (right to purchase)F6 | $0.80 | Jan 9, 2015 | M | 186,212 | D | — | Jan 20, 2015 | Common Stock | 186,212 | 597,595 | D |
| Stock Option (right to purchase)F6 | $0.80 | Jan 12, 2015 | M | 48,444 | D | — | Jan 20, 2015 | Common Stock | 48,444 | 549,151 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price of $0.9004 per share represents a weighted average of sales prices from $0.90 to $0.9098 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The price of $0.9155 per share represents a weighted average of sales prices from $0.90 to $0.945 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The price of $0.9137 per share represents a weighted average of sales prices from $0.90 to $0.9351 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F6Options vested and became exercisable based on the following schedule: 300,000 on January 20, 2006, 300,000 on January 20, 2007, and 400,000 on January 20, 2008.